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ARS2 is a stable component of the nuclear cap-binding complex (CBC) and is critical for RNA Polymerase II 
transcript processing. Moreover, ARS2, and its orthologue SERRATE in plants, has been implicated in having a 
role in most established CBC-dependent functions. This review will provide insight into the functions of 
ARS2/SERRATE in numerous RNA Polymerase II transcript processing events, which happen 
co-transcriptionally from initiation to termination, and post-transcriptionally during maturation and export into 
the cytoplasm. Additionally, we will discuss what is known regarding ARS2/SERRATE structure in plants and 
in mammals. 
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Introduction 
The early life of all RNA polymerase II (RNAP II) 
transcripts starts with the addition of a 7-methylguanosine 
(m7G) cap at the 5’-end [1]. The 5’-m7G cap is 
co-transcriptionally bound by the nuclear cap-binding 
complex (CBC), which, in addition to protecting the 
transcript from degradation, interacts with several 
multi-protein complexes in a mutually exclusive manner to 
couple the 5’-cap with transcript processing, turnover, and 
export. RNAP II generates several classes of RNA, including 
messenger RNA (mRNA), microRNA (miRNA), 
replication-dependent histone (RDH) mRNA, small nuclear 
RNA (snRNA), some small nucleolar RNA (snoRNA), and 
long noncoding RNA (lncRNA). Each of these RNA classes 
possess unique processing requirements. The interaction 
between the CBC and processing machinery is necessary for 
transcription termination, 3’-end formation, exosomal 
degradation, intranuclear transport, and export into the 
cytoplasm [2-11]. Precisely how the cap facilitates these 
disparate processes and discriminates between transcripts is 
not known. The cap-binding protein, ARS2, is a scaffold that 
interacts constitutively with CBP20/80 and the 5’-end cap to 
form a complex called CBCA [8, 10, 11], which mediates 
interactions between the cap complex and RNA 3’-end 
processing, shuttling, exosome, and export machinery. Thus, 
ARS2 is emerging as a critical factor, physically coupling 
multiple steps in the life of RNAP II transcripts.   
ARS2 was first identified as a gene that conferred arsenic 
REVIEW 
RNA & DISEASE 2017; 4: e1376. doi: 10.14800/rd.1376; © 2017 by Connor O’Sullivan, et al. 
http://www.smartscitech.com/index.php/rd 
Page 2 of 16 
resistance to cells [12]. This was later shown to be due to 
expression of a truncated cDNA that resulted in a 
dominant-negative phenotype; instead, ARS2 expression 
correlates with arsenic sensitivity [8]. Early genetic studies 
determined the requirements of ARS2, or its plant orthologue 
SERRATE (SE), during development. ARS2/SERRATE 
knockout results in embryonic lethality in plants, fission 
yeast, fruit flies, zebrafish, and mice [13-18]. Conditional Ars2 
knockout in hematopoietic tissues results in decreased 
cellularity in the bone marrow [8], while conditional knockout 
in mouse subventricular zone neural stem cells (NSCs) 
decreased neurogenic and self-renewal capacity [19]. 
Conversely, high levels of ARS2 in NSCs correlates with 
increased neurogenesis and an elongated life span in mice 
[20]. Additionally, there are several recent reports of ARS2 
dysregulation in human cancers [21-23]. Together, these 
findings indicate ARS2 has a vital role in the development 
and maintenance of diverse tissues and suggest that 
maintaining appropriate levels of ARS2 may be important for 
human disease.  
It is increasingly evident that ARS2 function is intimately 
intertwined with cap-binding proteins CBP20/80. 
Immunoprecipitation of either ARS2 or CBP20/80 pulls 
down a substantially overlapping set of proteins, implying a 
strong functional overlap [10, 11]. This is supported by 
loss-of-function experiments demonstrating ARS2 and 
CBP20/80 regulate similar transcripts, and phenotypically 
resemble one another [10, 11]. This review will emphasize the 
interactions mediated by ARS2, for additional reviews on the 
CBC please see [24, 25]. We will discuss the early functional 
studies linking ARS2/SERRATE to the CBC and miRNA 
and RDH biogenesis, review what is known about ARS2 
domain structure and function, as well as the recent “omic” 
data implicating ARS2 in linking transcription to the 
surveillance, export, and silencing machineries. The theme 
emerging is that ARS2 is involved in the regulation of most 
capped RNAP II transcripts. ARS2 acts as a scaffold protein 
able to bind both RNA and proteins and provide a physical 
link between the 5’-CBC and the protein complexes involved 
in 3’-end processing, maturation, degradation, export, and 
silencing. 
ARS2/SERRATE and microRNA biogenesis 
The first studies to characterize ARS2 function were in 
Arabidopsis with its orthologue SERRATE (SE). 
Hypomorphic mutations of SE in Arabidopsis result in 
pleiotropic developmental defects [26-28], which had 
overlapping phenotypes with mutants of genes involved in 
miRNA biogenesis, as well as with CBP80/ABH1 and 
CBP20 mutants [13, 27-31]. For reviews of miRNA biogenesis 
in Arabidopsis please refer to [32, 33]. Briefly, in Arabidopsis, 
pri-miRNAs are cleaved to miRNA in the nucleus by a 
complex composed of the RNase III enzyme DICER-LIKE 1 
(DCL1), the double-stranded (ds)RNA binding protein 
HYPONASTIC LEAVES 1 (HYL1), and the scaffold 
TOUGH (TGH) (Figure 1) [32]. Following DCL1 cleavage, 
the miRNA/miRNA* duplex is methylated by HEN1, which 
protects the miRNA from degradation, and is exported into 
the cytoplasm by HASTY [34-36]. Once exported, miRNA are 
bound by ARGONAUTE 1 (AGO1) and induce degradation 
or inhibit translation of its target transcripts [37, 38].   
Early studies showed that SE, within the context of the 
CBC, is required for proper miRNA biogenesis [13, 30]. SE 
physically interacts with pri-miRNA, as well as with the 
CBC [39-41]. Both cbp and se mutants accumulate levels of 
pri-miRNA [7, 42], indicating their involvement at the early 
stages of processing. Indeed, SE and HYL1 directly interact 
with DCL1 and are required for the efficient and accurate 
cleavage of pri-miRNA and pre-miRNA [40, 43-46]. SE also 
Figure 1. ARS2 and microRNA biogenesis. ARS2/SERRATE has a conserved role in miRNA biogenesis. A) In Arabidopsis SERRATE 
(SE) interacts with CBP80/ABH1 (80) and CBP20 (20) at the 5’ m7G cap (small yellow circle) and is required for efficient and accurate 
pri-miRNA cleavage by DCL1. SE also interacts with HYL1 and TGH. B, C) In Drosophila and mammals, ARS2 is required for efficient 
pri-miRNA cleavage by the Microprocessor, which consists of Drosha and Pasha. C) DGCR8 is the mammalian orthologue of Pasha. In 
mammals, ARS2 interacts with DROSHA and is required for efficient processing and miRNA stability. 
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interacts with the scaffold TGH [47]. HEN1 interacts with the 
same regions of DCL1 and HYL1 as SE, and does not 
interact with SE itself, supporting the notion that SE acts 
upstream of miRNA methylation and is possibly released in 
order for HEN1 to function [48].  
The role of ARS2/SERRATE and the CBC in miRNA 
biogenesis is conserved in metazoans [8, 49]. In mammals, 
RNAP II generates capped primary miRNA (pri-miRNA) 
transcripts [50, 51], which are trimmed in the nucleus by the 
Microprocessor complex consisting of the RNase III 
DROSHA and the RNA binding DiGeorge syndrome 
chromosomal region 8 (DGCR8) protein [52, 53]. ARS2 
interacts with DROSHA and is required for the stability and 
efficient processing of pri-miRNA to precursor miRNA 
(pre-miRNA) by the Microprocessor [8]. Interestingly, ARS2 
is thought to act as a cofactor for DROSHA, as it influences 
the efficiency and specificity of DROSHA activity [8, 9, 54].   
In Drosophila, the miRNA biogenesis process is very 
similar; pri-miRNAs are cleaved to pre-miRNA in the 
nucleus by the Microprocessor complex [55]. Following 
export into the cytoplasm, pre-miRNA are cleaved by 
Dicer-1 to generate mature miRNA, which are then loaded 
onto an Ago1-dependent RNA-induced silencing complex 
(RISC) [56-58]. As in mammals, Drosophila Ars2 (dArs2) 
interacts with the CBC and Microprocessor, and is required 
for pri-miRNA processing and stability [49]. Drosophila also 
use RNAi for innate immunity to protect against viral 
infection [49]. Viral dsRNA is processed into small interfering 
RNA (siRNA) by Dicer-2 in the cytoplasm [56, 59]. Dicer-2, 
along with the dsRNA-binding protein R2D2, are required 
for loading Ago2-RISC, which mediates siRNA silencing [56, 
59, 60]. Interestingly, dARS2 also interacts with cytoplasmic 
Dicer-2 and is required for the processing of presumably 
uncapped long dsRNA into siRNA [49]. Depletion of dArs2, 
CBP20, or CBP80 in flies results in an increased 
susceptibility to infections by RNA viruses, due to defective 
siRNA biogenesis [49]. Thus, ARS2, CBP20, and CBP80, 
may have cofactor roles in RNA processing that extend 
beyond their role in the nuclear cap complex. Collectively, 
this work established that ARS2/SE has a conserved role in 
miRNA biogenesis, and physically couples the CBC to the 
Microprocessor in insects and animals, or to DCL1 in plants 
(Figure 1). 
ARS2 and replication-dependent histone RNA 
The demonstration that ARS2/SERRATE is part of the 
CBC that physically bridges the cap to the Microprocessor, 
raised the possibility that ARS2 would be required for other 
CBC-dependent processes. The first indication of this came 
from work by Kiriyama et al. and Gruber et al. who showed 
that ARS2 is required for processing of 
replication-dependent histone (RDH) transcripts [9, 61]. As 
cells enter S phase, histone proteins are rapidly synthesized 
to package newly replicated DNA [62]. RDH transcripts are 
transcribed by RNAP II, m7G capped, and intronless [63]. At 
their 3’-ends, RDH transcripts contain a conserved 
stem-loop, and are the only known metazoan mRNA not 
polyadenylated [63]. Instead, RDH transcripts undergo 
endonucleolytic cleavage, via cleavage and polyadenylation 
specificity factor (CPSF) subunit CPSF73, between the 
conserved 3’-end stem-loop and a histone downstream 
element (HDE) [64-66]. RDH processing is cap-dependent and 
requires the coordination of several multimeric complexes. 
For example, the stem-loop is bound by stem-loop binding 
protein (SLBP), while the HDE base pairs with U7 snRNA, 
which is part of a multi-subunit U7 small nuclear 
ribonucleoprotein (snRNP) complex that acts as a molecular 
ruler to guide endonucleolytic cleavage by the histone 
pre-mRNA cleavage complex (HCC), which consists of 
CPSF73, CPSF100, and symplekin [67-72]. In addition, 
negative elongation factor (NELF) not only associates with 
histone loci at the promoter, but is also required for 
processing RDH pre-mRNA at the 3’-end (Figure 2) [6]. 
Misprocessing of RDH transcripts results in aberrant 
read-through and polyadenylation [9, 73].  
ARS2 mediates interactions with RDH pre-mRNA and 
components of the RDH 3’-processing machinery. CBP20/80 
Figure 2. ARS2 and replication-dependent histone processing. 
Binding of the U7 snRNP to the HDE and FLASH are required for 
endonucleolytic cleavage by CPSF73, which is part of a histone 
pre-mRNA cleavage complex (HCC). CBCA makes multiple contacts 
with the 3’ processing machinery, which are required for accurate 
cleavage. CBP80 interacts with SLBP and NELF, and ARS2 
interacts with FLASH. Additionally, histone 3’-end formation is 
negatively regulated by the noncoding 7SK RNA through an 
interaction with ARS2.  
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interacts with SLBP and negative elongation factor (NELF) 
[6, 11]. Meanwhile, mammalian ARS2 interacts with RDH 
RNA and FLICE-associated huge protein (FLASH) [9, 54, 61]. 
In turn, FLASH directly interacts with the U7 snRNP 
component LSM11, and is required for RDH pre-mRNA 
endonucleolytic cleavage [74-77]. Knockdown (KD) of either 
ARS2 or FLASH disrupts the formation of histone locus 
bodies (HLBs), increases aberrant polyadenylated histone 
transcripts, and decreases histone protein levels [9, 54, 61, 78]. 
Most likely as a result, cells deficient in either ARS2 or 
FLASH are delayed in S-phase progression [54, 61, 78]. As an 
added layer of complexity, the noncoding 7SK RNA, an 
important factor in regulating transcriptional elongation, 
interacts with ARS2 and negatively regulates RDH 3’-end 
processing, potentially by sequestering ARS2 [9]. Further 
work is needed to understand how 7SK RNA regulates 
ARS2, as well as the precise role of ARS2 in RDH 3’-end 
formation (Figure 2). Nevertheless, the finding that ARS2, as 
part of the CBC, interacts with both miRNA and RDH 
processing machinery suggested ARS2 has a broader role in 
physically coupling RNAP II transcript processing.  
ARS2/SERRATE structure/function 
The next important milestone in understanding ARS2 
function was obtaining the SE crystal structure by the Yuan 
Lab [46]. Their work showed that SE consists of 3 domains in 
a walking man-like conformation, with the domain of 
unknown function (DUF3546), Mid, and zinc finger (ZnF) 
domains forming the leading leg, body, and lagging leg, 
respectively; the N and C-termini are unstructured [46]. Using 
homology modeling, bioinformatics analysis and this critical 
structural information, our lab determined that the DUF3546, 
Mid and ZnF domains were conserved between plants and 
Figure 3. Mammalian ARS2 structure/function. A representation of mouse ARS2 domains (center) along with their 
reported interacting partners, based on [54]. The structured part of the protein consists of the domain of unknown function 
(DUF3546) shown in green, Mid domain in dark blue, and ZnF domain in purple. The orientation of the RRM (shown in 
cyan) relative to the core is unknown. The unstructured C-terminus (C-term) is required for interaction with CBP80/20, the 
Mid domain has been implicated as being important for interaction with DROSHA, the ZnF is required for RNA interaction, 
and FLASH through the FLASH ARS2 binding (FARB) peptide interacts with the ZnF and RRM. How ARS2 precisely 
contacts RNA/protein is not understood. CBP80/20 structure corresponds to PDB 1N52 [155], DROSHA to PDB 5B16 [53], 
and the RNA structure is from PDB 5DV7 [156]. 
RNA & DISEASE 2017; 4: e1376. doi: 10.14800/rd.1376; © 2017 by Connor O’Sullivan, et al. 
http://www.smartscitech.com/index.php/rd 
Page 5 of 16 
metazoans [54]. Additionally, we identified a previously 
uncharacterized RNA recognition motif (RRM) that is highly 
conserved within metazoans but absent in plants [54]. This 
information provided the basis for deletion and point mutant 
analysis to assess the functions of these domains in 
Arabidopsis and mammalian cells, respectively. 
The interactions between SE, DCL1, and RNA are 
primarily mediated through the unstructured arginine-rich 
N-terminus, ZnF domain and unstructured C-terminus [40, 46].
In vitro binding assays have mapped the RNA binding sites
to a strong affinity site located within the unstructured
N-terminus and a weaker site located within the ZnF domain
and unstructured C-terminus [40, 46]. Similarly, DCL1 interacts
both with the unstructured N-terminus and the ZnF domain
[40]. Interestingly, the unstructured N-terminus is dispensable
for pri-miRNA processing in vitro [40], suggesting the
interactions through the ZnF and unstructured C-terminus are
sufficient. In support of this hypothesis, the SE ZnF is
essential for stimulating pri-miRNA cleavage in vitro [40]. In
fact, the ZnF along with the C-terminal tail are sufficient to
rescue the se-1 mutant morphology and miRNA levels in
vivo [46]. Thus, the ZnF and C-terminus form a critical core
for miRNA processing, with additional non-essential
interactions formed through the N-terminus.
A somewhat different picture is emerging for mammalian 
ARS2 interactions. Point mutant analysis of mouse ARS2 
(mARS2) has revealed the ZnF domain is important for both 
protein and RNA interactions [54]. Mutations in the ZnF 
domain abolished interactions with both pri-miRNA and 
RDH pre-mRNA transcripts in a pull-down assay, and 
disrupted miRNA and RDH processing based on reporter 
assays [54]. The interaction between the ZnF and these RNA 
appears to be direct, as wildtype mARS2, but not the ZnF 
mutants, was able to associate with RNA under high salt 
wash conditions, which removed mARS2 associated proteins 
[54]. The ZnF domain is also required for interacting with 
FLASH through the FLASH ARS2 binding (FARB) peptide 
[54], indicating this domain can mediate both protein-protein 
and protein-RNA interactions (Figure 3). 
An important distinguishing feature of metazoan ARS2 is 
the presence of an RRM domain, which is inserted into an 
unstructured loop region between helix 4 and 5 of the Mid 
domain, and is predicted to fold similar to splicing factor 3b 
subunit 4 (SF3B4) [54]. Mutation analysis showed the ARS2 
RRM is important for histone expression and interactions 
with FLASH [54]. However, mutations of the RNP1 and 
RNP2 motifs within the domain did not affect binding to 
miRNA or RDH mRNA, suggesting this domain is not 
involved in RNA interactions [54]. It remains possible that the 
RRM may mediate interaction with other types of RNA, bind 
RNA through other regions of the domain not mutated, or 
exclusively interact with proteins, similar to Y14 and UPF3 
RRMs (Figure 3) [79, 80]. Further investigation is warranted to 
distinguish between these possibilities.  
The ARS2 DUF3546 domain is defined by three tyrosine 
residues that are conserved in yeast, plants, and metazoans, 
suggesting they are functionally important [54]. Mutating the 
conserved tyrosines to phenylalanine in mARS2 abolished 
interaction with pri-miRNA and RDH pre-mRNA in low salt 
conditions; however, the DUF mutant could bind RNA as 
efficiently as wildtype in high salt conditions [54]. These 
results point to an allosteric mechanism or an indirect effect 
through a RNA-binding cofactor at this site. Interestingly, 
published mass spectrometry data show ARS2 can be 
phosphorylated at Y172 [81] and Y175 [82] within the 
DUF3546 domain, suggesting the function of this domain 
may be regulated post-translationally by phosphorylation. In 
fission yeast, mutation of F165 in the DUF3546 domain 
contributes to a temperature sensitive allele [83]. How the 
DUF3546 domain regulates interactions with RNA requires 
further investigation. 
Mapping the interaction between mARS2 and DROSHA 
has proven to be difficult. In contrast to SE, mutations to the 
ZnF or deletion of the C-terminus did not affect binding to 
DROSHA [54]. Machida et al. originally proposed the idea 
that the Mid domain of SE/ARS2 may function as a platform 
for protein-protein interactions [46]. Consistent with this 
hypothesis, mutations in two separate regions of the mARS2 
Mid domain partially disrupted DROSHA pulldown and 
affected miRNA biogenesis as evidenced by reporter assays 
[54], thus implicating the Mid domain in DROSHA binding 
(Figure 3). However, the distance between the Mid domain 
mutation sites suggest these mutations likely locally disrupt 
the folding of this domain, and thus the exact binding site has 
not been elucidated. 
ARS2 interacts with the 5’-CBC through the unstructured 
proline-rich C-terminus [10, 54]. Using a yeast two-hybrid 
assay, Hallais et al. mapped the CBC interaction site to 
amino acids 502-871 of the C-terminus [10]. Using deletion 
analysis, our lab found that amino acids 763-875 were 
necessary to immunoprecipitate the CBC with ARS2 [54]. 
Interestingly, this region was also necessary for interactions 
with histone mRNA, as deleting this region abolished the 
ability of ARS2 to co-precipitate histone mRNA, but not 
miRNA [54]. This suggests that the ZnF domain alone is not 
sufficient for ARS2 to interact with RDH mRNA, and 
additional interactions are required, likely mediated through 
the C-terminus of ARS2 and the CBC. Collectively, this 
work established that ARS2, through its domains and 
unstructured termini, is able to interact with the CBC, 
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different types of RNA, and different unique processing 
machineries. Thus, ARS2 has the properties of a scaffold 
able to mediate multiple protein and RNA interactions, 
which positions it as an ideal candidate linking the cap 
complex to a broader role in RNAP II transcript processing. 
ARS2 and transcription termination 
Confirmation of a broader role in RNAP II transcription 
came with the demonstration that ARS2 and the CBC are 
required for inducing cap-proximal transcription termination 
for snRNA, RDH RNA, promoter upstream transcripts 
(PROMPTs) and mRNA. This was demonstrated through 
proteomic analysis using immunoprecipitations of the 
machinery involved in these processes, and knockdown 
experiments of ARS2 or CBP20/80, which increases 
3’-read-through transcripts for each of these RNA classes [10, 
11]. Interestingly, transcripts longer than ~1 kb were largely 
unaffected by ARS2 depletion with regards to 
3’-read-through [10], suggesting CBCA or a 
CBCA-interacting factor have a mechanism to limit their 
activity to promoter proximal areas. However, very little is 
currently known mechanistically about how ARS2 may 
interact with these processes.  
ARS2 and the exosome 
A major role of the CBC is in RNA quality control, and in 
limiting the effects of promiscuous RNAP II transcription. 
Recently, ARS2 was shown to participate in targeting 
transcripts to the nuclear RNA exosome through interaction 
with the human nuclear exosome targeting (NEXT) complex 
[11, 84]. This complex recruits the exosome to degrade 
PROMPTs and 3’-extended snRNA [11, 84-87]. NEXT is 
composed of the RNA helicase hMTR4, the zinc-knuckle 
ZCCHC8, and the RRM-containing RBM7 [11, 84]. Affinity 
capture mass spectrometry revealed a stoichiometric 
interaction between CBCA, NEXT, and another ZnF protein 
ZC3H18 [11]. Depletion of CBCA, NEXT components, or 
ZC3H18, results in accumulation of PROMPTs [10, 11]. RBM7 
associates with newly synthesized RNA, is enriched at 
regions close to the 5’-cap, and RBM7-RNA interaction is 
disrupted following CBC KD [85]. These data indicate that 
ARS2 and the CBC recruit the NEXT complex to newly 
synthesized RNAP II transcripts that are destined for 
exosomal destruction (Figure 4).  
The role of ARS2 and the cap complex in RNA quality 
control is conserved in fission yeast. In Schizosaccharomyces 
pombe (S. pombe), Pir2/Ars2 (yeast orthologue) and 
Cbc1-Cbc2 (orthologues of CBP80 and CBP20, respectively) 
interact with the Mtl1-Red1 core (MTREC) complex [88,89] 
(alternatively named nuclear RNA silencing (NURS) 
complex) [90]. Mtl1 is a Mtr4-like helicase and Red1 is a ZnF 
protein [88, 91]. Despite not having sequence similarities, 
CBCA-MTREC is likely the fission yeast functional 
equivalent of the human CBCA-NEXT complex. MTREC, 
along with Pir2/Ars2 and the CBC, are essential for targeting 
RNA to the exosome in S. pombe (Figure 4) [88-91]. Similar to 
the fate of PROMPTs in mammals, MTREC in S. pombe 
delivers polyadenylated cryptic unstable transcripts (CUTs) 
to the exosome for destruction [89].   
ARS2 and mRNA 3’-end processing 
3’-end processing of mRNA consists of endonucleolytic 
Figure 4. ARS2 and the exosome. A) CBC-ARS2 targets aberrant transcripts to the RNA exosome through the NEXT complex, 
composed of hMTR4, ZCCHC8 and RBM7, and the NEXT-associated protein ZC3H18. B) S. pombe Pir2/Ars2 and CBC proteins 
Cbc1/Cbc2 target aberrant transcripts to the exosome through the MTREC/NURS complex, minimally composed of Mtl1 and Red1, and 
associated with several subcomplexes, including the Erh1-Mmi1 complex (EMC) (see ARS2 and heterochromatin). 
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cleavage followed by polyadenylation. The cleavage and 
polyadenylation machinery are recruited co-transcriptionally 
through the CTD of RNAP II [92]. A large number of factors 
are required for proper mRNA processing. These include the 
multi-subunit CPSF, cleavage stimulation factor (CstF), 
cleavage factor Im (CFIm) and CFIIm complexes as well as 
poly(A) polymerase [93, 94]. CFIIm bridges RNAP II and the 
nascent transcript to CPSF and CFIm [95], and is required for 
pre-mRNA cleavage by CPSF73 prior to polyadenylation [93]. 
CBCA interacts with and stabilizes the pre-mRNA 
3’-processing machinery, and is required for efficient 
cleavage, but not polyadenylation of short pre-mRNA [5,10]. 
Interestingly, ARS2 was shown to interact with CFIIm 
component CLP1, and depletion of either ARS2, CLP1, or 
another CFIIm component PCF11, induces 3’-read-through 
reminiscent of CBCA KD, suggesting the interaction is 
functional (Figure 5A) [10,  96].  
ARS2 and snRNA 3’-end processing 
ARS2 is also required for snRNA 3’-end formation [10], a 
process which shares NELF with RDH 3’-end processing 
machinery [6, 97]. snRNA 3’-end formation is mediated by the 
twelve subunit Integrator complex that contains homologues 
of CPSF73 and CPSF100 (Int11 and Int9, respectively) [98]. 
NELF interacts with Integrator and is required for accurate 
snRNA 3’-processing [97]. Thus, similar to its role in RDH 
3’-end formation, CBCA may be affecting snRNA 
processing through an interaction with NELF (Figure 5B). 
ARS2 and export 
In metazoans, export of snRNA requires CBCA, 
phosphorylated adapter for RNA export (PHAX), the export 
receptor CRM1/XPO1, and RanGTP [99, 100]. PHAX directly 
interacts with the CBC and snRNA [10, 11, 100, 101]. Notably, 
ARS2 stimulates PHAX binding to the CBC, promoting the 
formation of a stable complex called CBCAP, composed of 
CBC, ARS2, and PHAX [10]. The mechanism underlying the 
allosteric regulation of PHAX binding by ARS2 is currently 
unclear and requires further investigation. However, PHAX 
is phosphorylated by CK2 kinase, and PHAX must be in its 
phosphorylated state in order for CRM1 to be recruited along 
with RanGTP, and for snRNA export to occur (Figure 6A) 
[100, 102]. In addition to snRNAs, the CBCAP complex can 
bind m7G capped snoRNAs, and PHAX binding is required 
for their intranuclear transport to Cajal bodies, where 
snoRNAs are further processed [10,103]. This suggests ARS2 
may also be involved in snoRNA transport. 
The mechanism of the specific interaction between PHAX 
and snRNA provides insight into understanding how 
different types of transcripts may be distinguished [10]. 
Differential processing of snRNAs is achieved through 
Figure 5. ARS2 and 3’-end formation. A) ARS2 is required for 3’-end cleavage by CPSF73 at short mRNA transcripts and PROMPTs, 
and interacts with CLP1/PCF11 of the CFIIm complex, which bridges the CPSF and CFIm complexes. The CstF complex and Poly(A) 
polymerase are also shown. B) ARS2 is also required for 3’-end formation by the Integrator complex at snRNA transcripts. CBCA may 
mediate an interaction with Integrator through NELF. 
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preferential binding of the heterogeneous nuclear 
ribonucleoprotein (hnRNP) C tetramer to transcripts longer 
than 200-300nt [104]. hnRNP C directly interacts with CBP80 
and RNA, and competitively inhibits PHAX binding [104]. 
Therefore, U snRNAs, which are typically <200 nt, bind 
PHAX by default and are exported via CRM1-RanGTP, 
while longer mRNA transcripts are inhibited from using this 
pathway through the action of hnRNP C (Figure 6B) [104, 105]. 
CBCA also plays an important role in mRNA export, 
largely mediated by the multisubunit transcription export 
(TREX) complex, which acts as an adaptor for the export 
receptor TAP/NXF1 [106-111]. Human TREX is composed of 
the THO complex (THOC1, THOC2, THOC5, THOC6, 
THOC7, Tex1), CIP29, UAP56 and ALY/REF [112-114]. 
TREX is involved in release of mRNA from nuclear speckle 
domains and coupling to the export receptor [115]. The 
presence of the exon junction complex (EJC), which is 
deposited following splicing, stimulates TREX recruitment 
[106, 107, 110, 112, 116], ensuring correctly processed transcripts are 
exported. Following binding of TREX subunits to mRNA, 
ALY/REF and THOC5 handover the mRNA to the 
TAP/NXF1-p15 heterodimer [117], which then transports the 
mRNA through the nuclear pore [111, 118].  
ALY/REF directly interacts with CBP20/80 [104, 119, 120], 
while THOC2, UAP56, and CIP29 independently interact 
with ARS2 [113], and these interactions are required for 
efficient mRNA export [120, 121]. ARS2 KD results in 
accumulation of mRNA in nuclear speckle domains [121]. 
Interestingly, Zinc-knuckle protein ZC3H18, which interacts 
with ARS2 as part of the CBC-NEXT complex [11, 84, 85], also 
interacts with the TREX complex [121]. ZC3H18 KD prevents 
efficient TREX recruitment to RNA and also results in an 
accumulation of mRNA in nuclear speckle domains [121]. 
Although the details are less understood, intronless mRNA 
also relies on components of this pathway, including CBCA, 
TREX, ZC3H18, and TAP/NXF1 [108, 109, 120, 121]. Thus, 
CBCA, through ZC3H18, may control recruitment of TREX 
and export of transcripts that are capped and correctly 
processed (Figure 6C). 
Recently, an alternative mammalian CBC was discovered 
where NCBP3 could bind CBP80 and the m7G cap in place 
of CBP20 [122]. Interestingly, both NCBP3 and CBP20 bound 
many common factors, including ARS2, and only double KD 
of NCBP3 and CBP20 significantly disrupted mRNA export, 
suggesting some redundancy between the two complexes; 
however, NCBP3 preferentially interacted with TREX, while 
CBP20 exclusively bound snRNA and PHAX, indicating 
these two complexes may have developed specialized 
functions in mRNA and snRNA export [122]. Deciphering the 
roles of this alternative CBC as well as how it interacts with 
ARS2 will be an exciting area of research. 
ARS2/SERRATE and splicing 
Pre-mRNA splicing, whereby introns are removed and 
exons are ligated together in a two-step transesterification 
reaction, is carried out by the spliceosome complex. For 
excellent, detailed reviews on splicing, see [123-125]. In 
Arabidopsis, CBP80/ABH1, CBP20 and SE are required for 
Figure 6. ARS2 and export. A) ARS2 mediates snRNA export by stimulating phosphorylated adaptor for RNA export (PHAX) binding to 
CBC, forming the CBCAP complex. snRNA bound to CBCAP is then exported by CRM1/RanGTP. B) Transcripts longer than ~200-300 nt 
are bound by the hnRNP C tetramer, which interacts with the CBC and inhibits PHAX binding, thereby committing them to the mRNA 
export pathway (left). Splicing and the presence of CBCA, ZC3H18, and the exon junction complex (EJC) stimulates TREX recruitment to 
the 5’-end of mRNA. The export adaptor ALY/REF, a component of TREX, mediates handover to TAP/NXF1 and p15 for export into the 
cytoplasm (right). 
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cap-proximal splicing and alternative splicing, as mutants 
primarily affect retention of the first intron and alternative 
5’-splice site selection [7, 41, 126]. The mechanistic details of 
how SE mediates splicing have not been resolved. In 
mammals, the CBC facilitates cap-proximal splicing, 
interacts with the U4/U6·U5 tri-snRNP in a 
RNA-independent manner, is required for co-transcriptional 
spliceosome assembly, and is involved in alternative splicing 
[127-130]. Although mammalian ARS2 co-purifies with 
multiple splicing factors [11, 131, 132], whether ARS2 directly 
participates in splicing in metazoans has not been 
established.    
ARS2 and heterochromatin formation 
Recently, a requirement for ARS2 in heterochromatin 
formation has been shown in fission yeast. In S. pombe, 
Pir2/Ars2 is required for heterochromatin formation at 
centromeres, telomeres, heterochromatin domains (HOODs), 
and a subset of meiotic loci [83, 90]. Pir2/Ars2 KD results in 
decreased histone H3 lysine 9 methylation (H3K9me) levels 
at these sites, a hallmark of heterochromatin formation [83,90]. 
The requirement of Pir2/Ars2 for heterochromatin formation 
at these diverse regions involves several partially 
overlapping pathways. The best characterized pathway is 
centromeric silencing, which is mediated by RNA 
interference (RNAi) machinery and heterochromatin 
formation [133], and requires Pir2/Ars2 [83, 90]. Transcription 
from repeat elements in these regions forms dsRNAs, which 
are cleaved by Dicer to generate siRNAs that are loaded onto 
an Ago1-containing RNA-induced transcriptional silencing 
(RITS) complex [134]. RITS then targets the complex to 
peri-centromeric regions for silencing and heterochromatin 
formation [134]. RITS is composed of Ago1, the 
chromodomain protein Chp1, and the GW protein Tas3 
[134,135]. Heterochromatin formation is mediated through an 
association between the RITS complex and the 
Clr4-Rik1-Cul4 (CLRC) complex, comprised of Clr4, a 
histone methyltransferase, Rik1, a heterochromatin targeting 
protein, and Cul4, an E3 ubiquitin ligase [136]. Together, 
RITS and the CLRC complex are responsible for the 
initiation of H3K9me [137]. Clr4 then binds to H3K9me and 
promotes the spread of heterochromatin [137]. Given the 
ability of dArs2 to associate with Dicer2 in Drosophila, and 
dArs2’s role in siRNA biogenesis in this organism [49], it is 
possible that Pir2/Ars2 is regulating heterochromatin at the 
centromeres through interactions with Dicer. However, 
Pir2/Ars2 also associates with RITS-associated CLRC 
complex in pull-down assays, and therefore likely has 
additional roles in silencing beyond enhancing Dicer activity 
(Figure 7A) [90].  
The second Pir2/Ars2-dependent pathway for 
heterochromatin formation is through the Ccr4-Not complex. 
This complex, along with Pir2/Ars2, mediates 
heterochromatin formation at telomeres, HOODs, and a 
subset of meiotic loci [83]. Ccr4-Not in S. pombe is comprised 
of Ccr4, Caf1, Caf40, and five Not proteins (Not1-5) [138]. 
Ccr4-Not has deadenylation (Ccr4 and Caf1) and 
ubiquitination (Not4) activity and is responsible for mRNA 
Figure 7. ARS2 and heterochromatin. A) S. pombe Pir2/Ars2 is required for heterochromatin formation at centromeres. Centromeric 
heterochromatin formation requires RNAi machinery (Dicer1 and RITS) as well as CLRC. Whether Pir2/Ars2 mediates centromeric 
heterochromatin through Dicer1, RITS and/or CLRC requires further study. B) Pir2/Ars2 also regulates heterochromatin formation at 
telomeres and heterochromatin domains (HOODs) in a Ccr4-Not dependent manner. C) Pir2/Ars2 regulates heterochromatin at a subset of 
meiotic loci through RNAi-independent and RNAi-dependent mechanisms. The RNAi-independent subset is thought to be mediated by the 
EMC through its ability to recruit MTREC and Ccr4-Not. The RNAi-dependent subset requires RITS and CRLC, which are thought to be 
recruited through the EMC. D) Human ARS2 regulates telomeric repeat-containing RNA (TERRA), which interact with the CLR4/SUV39H1 
methyltransferase and are correlated with H3K9me levels. The mechanism of TERRA regulation by ARS2 and its involvement in telomeric 
heterochromatin formation is not known (indicated by question mark).  
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turnover in the cytoplasm [138]. Interestingly, both enzymatic 
activities of the complex are required for heterochromatin 
formation, although the mechanisms behind these 
requirements is currently unclear [139]. Pir2/Ars2 co-purifies 
with all seven subunits of the Ccr4-Not complex, and 
heterochromatin formation at telomeres, HOODS, and some 
meiotic islands is Pir2/Ars2/Ccr4-Not-dependent (Figure 7B) 
[83]. A similar role for dArs2 and CCR4-NOT was found in 
retrotransposon silencing at telomeres in Drosophila [140, 141].  
Meiotic loci in fission yeast represent a third type of 
heterochromatin silencing. Meiotic transcripts contain a 
determinant of selective removal (DSR) sequence in their 
3’-UTR, recognized during the vegetative state by Mmi1, 
part of the Erh1-Mmi1 complex (EMC), which targets them 
for degradation via the exosome (Figure 7) [83, 88, 90, 91, 142]. 
The EMC is also required for heterochromatin formation at 
meiotic loci during the vegetative state through both 
RNAi-independent and RNAi-dependent mechanisms [83]. 
The RNAi-independent process is facilitated through the 
ability of the EMC to recruit MTREC and the exosome [83, 
88-91, 143], and is thought to rely on the ability of the MTREC
complex to independently interact with the Ccr4-Not
complex to mediate H3K9me [83, 138, 139]. An alternative
mechanism of meiotic loci silencing is RNAi-dependent and
is mediated through the EMC’s ability to recruit the RITS
complex and associated CLRC [83, 144]. Both RNAi-dependent
and -independent processes rely on Pir2/Ars2 (Figure 7C)
[83,90], but it is currently unclear how Pir2/Ars2 is restricted to
a subset of meiotic loci.
In humans, ARS2 has been implicated in telomeric 
heterochromatin formation through its regulation of long 
noncoding telomeric repeat-containing RNA (TERRA) [145]. 
TERRA are transcribed by RNAP II, associate with 
telomeric DNA, and have been implicated in telomere 
maintenance [146]. ARS2 co-purifies with TERRA, and ARS2 
KD in HeLa cells increases TERRA levels and the 
abundance of TERRA associated with telomeres [145]. 
Furthermore, TERRA itself directly interacts with the human 
homolog of the yeast Clr4 histone methyltransferase 
(SUV39H1) [147], and H3K9me levels are correlated with 
TERRA levels [147-149]. In Arabidopsis, SE and 
CBP80/CBP20 regulate the levels of hundreds of long 
noncoding RNAs (lncRNAs) [150]. Thus, the role of ARS2 in 
lncRNA biogenesis is conserved, and ARS2 is likely 
important for the function of other lncRNAs in mammals. 
Taken together, ARS2 is tied to heterochromatin formation at 
diverse regions using multiple pathways in yeast and 
metazoans (Figure 7D). 
An anomalous role for ARS2 as a transcription factor 
The vast majority of ARS2 functions involve its 
interactions with CBP20/80. However, there is one report of 
ARS2 as a transcription factor that does not fit this model. As 
mentioned, ARS2 has a key role in maintaining NSCs in the 
mouse brain [19]. Conditional Ars2 knockout in NSCs 
decreased their self-renewal capacity and multipotency, with 
their fate skewed towards astroglial production [19]. This 
phenotype was rescued by SOX2, a transcription factor 
essential for NSC maintenance [19]. Curiously, ARS2 bound 
to a small region within the SOX2 enhancer in a 
RNA-independent but cell type-dependent manner [19]. The 
presence of this enhancer region was necessary for SOX2 
luciferase reporter expression following ARS2 
overexpression [19]. Furthermore, expression of SOX2 was 
sufficient to rescue the defects in NSC self-renewal and 
multipotency of ARS2-deficient animals [19]. This work 
implicated ARS2 as a transcription factor. However, how 
ARS2 regulates SOX2 transcription is currently unclear. It is 
complicated by the fact that the Sox2 gene is located within 
an intron of the lncRNA SOX2OT (overlapping transcript) 
[151], and SOX2OT positively regulates SOX2 [152-154]. As 
mentioned, ARS2 is implicated in lncRNA function. Thus, it 
is plausible that some of the effects of ARS2 on SOX2 
expression may be related to ARS2 regulation of SOX2OT 
biogenesis. Further work is needed to discern the precise role 
of ARS2 in SOX2 expression.  
Concluding Remarks 
RNAP II transcription, from initiation to termination and 
export, is a highly coordinated multistep process that requires 
the CBC, yet there is little information on how this 
coordination is mediated. ARS2/SE is emerging as a critical 
component of the nuclear CBC, able to form a physical link 
between the CBC and numerous protein complexes that 
regulate different steps in RNAP II transcript biogenesis, 
turnover, and export. In yeast, these processes are also 
coupled to epigenetic chromatin modifications. Whether this 
coupling of RNA turnover to heterochromatin formation is 
conserved in metazoans remains an open question. However, 
the recent discovery of the role of ARS2 in Drosophila 
germline telomeric repeat silencing and TERRA regulation 
in humans suggests similar mechanisms, potentially 
lncRNA-dependent, will occur in metazoans. Understanding 
how ARS2 functions in these diverse processes will provide 
insight into the mechanisms of how these diverse processes 
are functionally coupled.   
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